Hardware-agnostic software developer Zapata Quantum has successfully finalized its corporate market expansion, uplisting its common stock onto the OTCQB Venture Market under its existing ticker symbol ZPTA. Following a rigorous operational compliance audit and management governance certification process, the transition relocates the enterprise onto an established institutional platform engineered to enhance public liquidity parameters and retail investor transparency. Company leadership frames the regulatory milestone as a critical transitional step within its multi-tier capitalization roadmap aimed at meeting the stringent qualitative and quantitative listing thresholds required for an upcoming national securities exchange deployment.
The strategic repositioning spotlights Zapata’s role as a rare pure-play public proxy for the domestic quantum computing software sector. Originally incubated within Harvard University’s quantum computing research laboratories, the enterprise holds an active portfolio of over 60 granted and pending algorithmic patents tracking across cryptographic validation, material optimization, and financial forecasting systems. The company remains the only pure-play algorithmic developer to maintain a continuous, multi-disciplinary research footprint spanning all primary technical sectors of DARPA’s rigorous Quantum Benchmarking program, while its joint structural simulation exploring quantum-enabled drug discovery was formally recognized among Nature Biotechnology’s Top 10 Papers of 2025.
Operating under the oversight of CEO Sumit Kapur, Zapata’s operational structure focuses on decoupling complex enterprise mathematical workflows from native hardware-level noise constraints. By developing highly compressed, compiler-neutral application layers, the firm builds out functional interfaces that allow Fortune 500 enterprises and defense agencies to deploy quantum subroutines directly into existing high-performance computing pipelines. The OTCQB venue will mandate verified, real-time market reporting structures, reinforcing corporate disclosure governance as the returning founder group works to secure expanded pilot contract deployments across the commercial life sciences and public cryptography defense spaces.
The official, real-time transaction indices and financial verification statements can be monitored directly on the OTC Markets Group Portal here. For a comprehensive breakdown of the company’s patent landscape, corporate capitalization metrics, and baseline balance sheets, inspect the investor reports on the Zapata Quantum Investor Relations Repository here, and the Nature Biotechnology’s paper here.
June 16, 2026
